A school-based vision screening program in kindergarten, shown to be effective at identifying untreated vision problems in 1 in 10 students, could be useful to implement widely in diverse communities, according to new research in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191085.
People with early-stage glaucoma see the contrast of visible objects in a very similar way to people without the condition, a new study has shown.
An international team of researchers led by Baylor College of Medicine and Houston Methodist has discovered a strategy that can potentially address a major challenge to the current treatment for age-related macular degeneration,
We humans may not always see eye to eye on politics, religion, sports and other matters of debate. And now it turns out we also cannot agree on the location and size of objects in our physical surroundings, according to new research from the University of California, Berkeley.
The latest Johns Hopkins Medicine research achievements and clinical advances covering topics not related to COVID-19 or the SARS-CoV-2 virus.
The mental state and ocular surface state of ophthalmologists and ophthalmic nurses during the COVID-19 outbreak in China in Wuhan and Jiangxi are analyzed in this survey study.
Older adults with both hearing and visual impairments--or dual sensory impairment--had a significantly higher risk for dementia in a recent study published in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring.
In experiments in rats and mice, two Johns Hopkins scientists -- an engineer and an ophthalmologist -- report the successful use of nanoparticles to deliver gene therapy for blinding eye disease. A uniquely engineered large molecule allows researchers to compact large bundles of therapeutic DNA to be delivered into the cells of the eye.
Exercise can slow or prevent the development of macular degeneration and may benefit other common causes of vision loss, such as glaucoma and diabetic retinopathy, new research suggests.
A new approach in ophthalmology that offers a revolutionary alternative to corneal transplantation has just been developed by researchers and clinicians in North America, Europe, and Oceania.